• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.在瑞士门诊精神科环境中扩大丙型肝炎筛查和治疗：一项成本效益分析。
JHEP Rep. 2022 Mar 4;4(5):100464. doi: 10.1016/j.jhepr.2022.100464. eCollection 2022 May.
2
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.在瑞士监禁环境中对扩大丙型肝炎病毒筛查及使用直接抗病毒药物治疗的影响和成本效益进行建模
Clin Infect Dis. 2019 Nov 13;69(11):1980-1986. doi: 10.1093/cid/ciz088.
3
Assessing the cost-effectiveness of hepatitis C screening strategies in France.评估法国丙型肝炎筛查策略的成本效益。
J Hepatol. 2018 Oct;69(4):785-792. doi: 10.1016/j.jhep.2018.05.027. Epub 2018 Jul 1.
4
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.美国初级保健环境中基于出生队列的丙型肝炎抗体筛查的成本效益分析。
Ann Intern Med. 2012 Feb 21;156(4):263-70. doi: 10.7326/0003-4819-156-4-201202210-00378. Epub 2011 Nov 4.
5
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.直接作用、泛基因型治疗方案时代丙型肝炎病毒感染普遍筛查的成本效益。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):930-939.e9. doi: 10.1016/j.cgh.2018.08.080. Epub 2018 Sep 8.
6
Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea.韩国增加慢性丙型肝炎筛查和治疗的成本效益分析。
Curr Med Res Opin. 2020 Jun;36(6):993-1002. doi: 10.1080/03007995.2020.1756232. Epub 2020 May 2.
7
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment.直接作用抗病毒药物治疗丙型肝炎的基层医疗与医院专科医疗的成本效益分析。
Int J Drug Policy. 2020 Feb;76:102633. doi: 10.1016/j.drugpo.2019.102633. Epub 2019 Dec 20.
8
[Cost-effectiveness of community-based treatment of chronic hepatitis B in China].[中国社区慢性乙型肝炎治疗的成本效益分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jul 10;38(7):860-867. doi: 10.3760/cma.j.issn.0254-6450.2017.07.004.
9
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.瑞士慢性丙型肝炎的微量消除：模拟瑞士肝炎战略在东部、西部和北部地区的目标
Swiss Med Wkly. 2019 Jan 23;149:w14694. doi: 10.4414/smw.2019.14694. eCollection 2019 Jan 14.
10
Cost-effectiveness of screening for hepatitis C in Canada.加拿大丙型肝炎筛查的成本效益
CMAJ. 2015 Feb 17;187(3):E110-E121. doi: 10.1503/cmaj.140711. Epub 2015 Jan 12.

本文引用的文献

1
HCV disease burden and population segments in Switzerland.瑞士的 HCV 疾病负担和人群分布。
Liver Int. 2022 Feb;42(2):330-339. doi: 10.1111/liv.15111. Epub 2021 Dec 10.
2
Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy.精神科环境中的丙型肝炎患病率：扩大筛查和直接抗病毒治疗的成本效益
JHEP Rep. 2021 Mar 18;3(3):100279. doi: 10.1016/j.jhepr.2021.100279. eCollection 2021 Jun.
3
Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients.直接作用抗病毒药物与 HCV 感染患者的阿片类药物、酒精或滥用非法药物的相互作用。
Liver Int. 2020 Jan;40(1):32-44. doi: 10.1111/liv.14283. Epub 2019 Nov 12.
4
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.在瑞士监禁环境中对扩大丙型肝炎病毒筛查及使用直接抗病毒药物治疗的影响和成本效益进行建模
Clin Infect Dis. 2019 Nov 13;69(11):1980-1986. doi: 10.1093/cid/ciz088.
5
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis.在瑞士，使用快速抗体唾液和干血斑检测法提高注射毒品人群丙型肝炎病毒筛查率的成本效益分析。
J Viral Hepat. 2019 Feb;26(2):236-245. doi: 10.1111/jvh.13023. Epub 2018 Nov 14.
6
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.分散式与集中式药物替代方案中丙型肝炎的管理以及用于弥合丙型肝炎病毒治疗流程差距的微创即时检测
Swiss Med Wkly. 2017 Nov 20;147:w14544. doi: 10.4414/smw.2017.14544. eCollection 2017.
7
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis.严重精神疾病患者中艾滋病毒、乙型肝炎和丙型肝炎的患病率：一项系统评价和荟萃分析。
Lancet Psychiatry. 2016 Jan;3(1):40-48. doi: 10.1016/S2215-0366(15)00357-0. Epub 2015 Nov 29.

Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.

作者信息

Girardin François, Tuch Alexandre, Eddowes Lucy, Preisig Martin, Negro Francesco

机构信息

Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.

Swiss Health Observatory [Obsan], Neuchâtel, Switzerland.

出版信息

JHEP Rep. 2022 Mar 4;4(5):100464. doi: 10.1016/j.jhepr.2022.100464. eCollection 2022 May.

DOI:10.1016/j.jhepr.2022.100464
PMID:35368992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8971934/
Abstract
摘要